PharmaVoice Logo

Healthcare Leaders Hub

Scientists claim Nobel Prize for approach behind light-activated gene therapy  

Pharma Tech

Scientists claim Nobel Prize for approach behind light-activated gene therapy  

The Nobel Prize committee says that optogenetics will lay the foundations for a new era in neuroscience, as pharma explores its role on treating ophthalmic conditions.

Read Full Article
Rethinking L-Glutamine in Pancreatic Cancer: Willis Lee on Emmaus’ Emerging PDAC Strategy

PharmaShots

Rethinking L-Glutamine in Pancreatic Cancer: Willis Lee on Emmaus’ Emerging PDAC Strategy

Shots     Saurabh: The GlutaPanc Phase 1 study reported encouraging results with L-glutamine in combination with gemcitabine and nab-paclitaxel. What are the most important takeaways from the study for the pancreatic cancer community and for Emmaus?  Willis: These promising findings in patients with advanced PDAC suggest significantly improved survivability without introducing untoward adverse events. This combination… The post Rethinking L-Glutamine in Pancreatic Cancer: Willis Lee on Emmaus’ Emerging PDAC Strategy appeared first on PharmaShots.

Read Full Article
Getting glutathione into the blood is not the same as getting glutathione into the cell

Express Pharma

Getting glutathione into the blood is not the same as getting glutathione into the cell

Skin Beyond Borders announced its audited skincare marketplace in August. What industry gap are you trying to address? My experience in the industry spans around 20 years. I formally started working in dermatology in 2009, although before that I was in formulation development and clinical research. In 2009 I started Adroit Digital Ideas, a medical […] The post Getting glutathione into the blood is not the same as getting glutathione into the cell appeared first on Express Pharma.

Read Full Article
Does India Pharma Inc need a new blueprint?

Express Pharma

Does India Pharma Inc need a new blueprint?

The open letter from nine EU pharma leaders and China’s new five year pharma plan are the latest and clearest signals that the stakes are only getting higher The post Does India Pharma Inc need a new blueprint? appeared first on Express Pharma.

Read Full Article
GLP-1RA non-responders: tackling a hidden challenge behind the obesity epidemic 

Pharma Tech

GLP-1RA non-responders: tackling a hidden challenge behind the obesity epidemic 

Improving outcomes for patients classed as ‘non-responders’ to GLP-1RA drugs remains a key unmet need within the obesity space.

Read Full Article

Sponsored content

Featured promotional

No active ads for this placement yet.

News

Latest stories

Pharma Tech

Oct 5, 2026, 3:02 PM

Scientists claim Nobel Prize for approach behind light-activated gene therapy  

The Nobel Prize committee says that optogenetics will lay the foundations for a new era in neuroscience, as pharma explores its role on treating ophthalmic conditions.

ET Pharma

Oct 5, 2026, 1:45 PM

CSL strikes rare disease drug deal worth up to $1.6 Bn with Swiss firm Alentis

Under the partnership, CSL will make an upfront payment of $355 million, while Alentis is eligible for up to $1.2 billion in commercial milestone payments.

ET Pharma

Oct 5, 2026, 1:36 PM

Serum Institute’s HPV vaccine secures Pre-qualification status from WHO

The recombinant quadrivalent vaccine targets high-risk HPV strains which accounts for more than 70 per cent of cervical cancer cases globally. SII developed the vaccine in collaboration with DPT, BIRAC, WHO-IARC and the Gates Foundation.

PharmaShots

Oct 5, 2026, 1:30 PM

Rethinking L-Glutamine in Pancreatic Cancer: Willis Lee on Emmaus’ Emerging PDAC Strategy

Shots     Saurabh: The GlutaPanc Phase 1 study reported encouraging results with L-glutamine in combination with gemcitabine and nab-paclitaxel. What are the most important takeaways from the study for the pancreatic cancer community and for Emmaus?  Willis: These promising findings in patients with advanced PDAC suggest significantly improved survivability without introducing untoward adverse events. This combination… The post Rethinking L-Glutamine in Pancreatic Cancer: Willis Lee on Emmaus’ Emerging PDAC Strategy appeared first on PharmaShots.

PharmaShots

Oct 5, 2026, 12:30 PM

The US FDA Approves Eli Lilly’s Jaypirca (Pirtobrutinib) for Certain Patients with Previously Untreated CLL/SLL

Shots: Ref: Eli Lilly  |   Image: Eli Lilly   |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post The US FDA Approves Eli Lilly’s Jaypirca (Pirtobrutinib) for Certain Patients with Previously Untreated CLL/SLL appeared first on PharmaShots.

Express Pharma

Oct 5, 2026, 12:02 PM

Getting glutathione into the blood is not the same as getting glutathione into the cell

Skin Beyond Borders announced its audited skincare marketplace in August. What industry gap are you trying to address? My experience in the industry spans around 20 years. I formally started working in dermatology in 2009, although before that I was in formulation development and clinical research. In 2009 I started Adroit Digital Ideas, a medical […] The post Getting glutathione into the blood is not the same as getting glutathione into the cell appeared first on Express Pharma.

News

Latest industry coverage

Google News

Oct 5, 2026, 9:00 PM

Can Continuous Tableting End Scale-Up for Complex Oral Drugs? - pharmtech.com

Can Continuous Tableting End Scale-Up for Complex Oral Drugs?  pharmtech.com

Google News

Oct 5, 2026, 9:00 PM

Sterling Expands ADC Manufacturing Capacity and Capabilities - CHEManager

Sterling Expands ADC Manufacturing Capacity and Capabilities  CHEManager

Google News

Oct 5, 2026, 8:54 PM

How AI is transforming biopharma manufacturing facilities of the future - BioPharma Dive

How AI is transforming biopharma manufacturing facilities of the future  BioPharma Dive

Google News

Oct 5, 2026, 8:05 PM

BioMarin Appoints Cara Bauer as Chief People Officer - PR Newswire

BioMarin Appoints Cara Bauer as Chief People Officer  PR Newswire

Google News

Oct 5, 2026, 8:01 PM

BJP govt takes hefty cuts, cannot rein in pharma cos: Akhilesh - The Times of India

BJP govt takes hefty cuts, cannot rein in pharma cos: Akhilesh  The Times of India

Google News

Oct 5, 2026, 7:46 PM

Curia Invests $28M to Expand Sterile API Manufacturing Capability - contractpharma.com

Curia Invests $28M to Expand Sterile API Manufacturing Capability  contractpharma.com

Google News

Oct 5, 2026, 7:41 PM

News | Pharmaceutical giant starts construction of manufacturing campus in Houston - CoStar

News | Pharmaceutical giant starts construction of manufacturing campus in Houston  CoStar

Google News

Oct 5, 2026, 7:22 PM

MedPharm Secures Fifth Commercial Manufacturing Deal in 20 Months - contractpharma.com

MedPharm Secures Fifth Commercial Manufacturing Deal in 20 Months  contractpharma.com

Google News

Oct 5, 2026, 6:58 PM

Exclusive: Genentech parts ways with a key AI leader in latest high-profile exit - Endpoints News

Exclusive: Genentech parts ways with a key AI leader in latest high-profile exit  Endpoints News

Sponsored placement

Featured promotions

No active ads for this placement yet.